Neuropeptide Y and derivates are not ready for prime time in prostate cancer early detection
Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related peptides compared with prostate-specific antigen (PS...
Những tác giả chính: | Maurer, J, Eugster, PJ, Collins, K, Vocat, C, Oke, J, Nicholson, B, Rakauskas, A, Grouzmann, E, Valerio, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2024
|
Những quyển sách tương tự
-
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection
Bằng: Jonathan Maurer, et al.
Được phát hành: (2024-08-01) -
Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?
Bằng: Alexander Meisel
Được phát hành: (2019-12-01) -
Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men
Bằng: Nicolas Bourdillon, et al.
Được phát hành: (2022-12-01) -
Biomarkers in early-stage colorectal cancer: ready for prime time?
Bằng: Church, D, et al.
Được phát hành: (2012) -
REBOA: is it ready for prime time?
Bằng: Jay Doucet, et al.